3SBio Inc. Registered Shares DL -,00001

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

21.05%

Market Cap

-

P/E Ratio

6.36

Dividend Yield

1.03 %

Earnings per Share

0.43 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE1.658 G0 Units
PRICE DETERMINATION TIME06/05/2026 / 09:56:33 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW1.71821.658
PREV. DAY'S PRICE1.7474 (06/04)
CHANGE DAY BEFORE
-0.09
-5.12 %
52 WEEK HIGH / LOW3.82 (09/09)1.658 (06/05)
More Price Information

Key Figures (in EUR)

2027e2026e202520242023
EARNINGS PER SHARE0.150.130.430.110.08
DIVIDENDS PER SHARE0.030.030.030.030.03
DIVIDEND YIELD IN %--1.03 %4.11 %3.32 %
DIVIDEND GROWTH IN %---4.03 %0.28 %143.22 %
PRICE - EARNINGS RATIO13.8915.366.366.5010.71
PRICE - BOOK RATIO--2.000.871.17
PRICE - SALES RATIO--3.111.522.13
PRICE - CASH FLOW RATIO--5.613.918.07
Further Key Figures

Master Data

WKN
A14T7Q
ISIN
KYG8875G1029
SYMBOL
83B
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
3SBIO INC. DL -,00001
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
-
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
-
MARKET CAPITALISATION
-

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-15.92 %
-30.04 %
-21.79 %
-48.83 %
-21.05 %
82.20 %
69.81 %
-38.13 %
HIGH2.012.452.783.183.823.823.823.12
LOW1.661.661.661.661.660.560.541.66
Dividend
per share

Company profile

3SBio, Inc. operates as an investment holding company, which engages in the development, production, marketing, and sale of biopharmaceutical products. Its products are used in the field of medicine, particularly in nephrology, oncology, supportive cancer care, inflammation, and infectious diseases. It operates through the Mainland China and Others geographical segments. The company was founded by Jing Lou and Dan Lou in 1993 and is headquartered in Shenyang, China.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.